Research / ADI / Fundamental state Inspectable configuration
State dimensions Filing 0000006281-23-000152 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
199.73% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 100th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.capex_revenue_ratio
8.71% · OPTIONAL · VALID
Operating cash generation 28th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
33.15% · OPTIONAL · VALID
Share-count growth 0th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.shares_outstanding
-3.54% · CORE · VALID
Revenue growth 36th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
9.79% · CORE · VALID
Inventory pressure 100th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
50.51% · OPTIONAL · VALID
Gross margin 44th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.gross_margin
65.72% · CORE · VALID
Operating margin 89th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.operating_margin
34.58% · CORE · VALID
R&D intensity 0th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
12.74% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.12% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Oct 30, 2021 9/9 normalized Level 3 Jan 29, 2022 9/10 normalized Level 3 Apr 30, 2022 9/10 normalized Level 3 Jul 30, 2022 9/10 normalized Level 3 Oct 29, 2022 9/9 normalized Level 3 Jan 28, 2023 9/10 normalized Level 3 Apr 29, 2023 9/10 normalized Level 3 Jul 29, 2023 9/10 normalized Level 3 Oct 28, 2023 9/10 normalized Level 3 Feb 3, 2024 9/10 normalized Level 3 May 4, 2024 10/10 normalized Level 3 Aug 3, 2024 10/10 normalized Level 3 Nov 2, 2024 10/10 normalized Level 3 Feb 1, 2025 10/10 normalized Level 3 May 3, 2025 10/10 normalized Level 3 Aug 2, 2025 10/10 normalized Level 3 Nov 1, 2025 10/10 normalized Level 3 Jan 31, 2026 10/10 normalized Level 3 May 2, 2026 10/10 normalized Level 3 Aug 1, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 202.39%
Current 199.73%
Delta -2.66% Capex Intensity Increased
Previous 5.42%
Current 8.71%
Delta 3.29% Cash Generation Decreased
Previous 43.28%
Current 33.15%
Delta -10.13% Dilution Decreased
Previous -3.34%
Current -3.54%
Delta -0.20% Growth Decreased
Previous 21.06%
Current 9.79%
Delta -11.27% Inventory Pressure Increased
Previous 46.87%
Current 50.51%
Delta 3.65% Margin Increased
Previous 65.37%
Current 65.72%
Delta 0.35% Profitability Decreased
Previous 34.80%
Current 34.58%
Delta -0.22% R And D Intensity Decreased
Previous 12.74%
Current 12.74%
Delta -0.00% Sbc Intensity Decreased
Previous 2.31%
Current 2.12%
Delta -0.19% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.